Measurement for Viral Reservoir and Immune Function in HIV-1-infected Patients Under Antiretroviral Therapy
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04068441 |
Recruitment Status :
Recruiting
First Posted : August 28, 2019
Last Update Posted : September 23, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
HIV-1-infection | Other: no intervention |
Study Type : | Observational |
Estimated Enrollment : | 50 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Measurement for Viral Reservoir and Immune Function in HIV-1-infected Patients Under Antiretroviral Therapy |
Actual Study Start Date : | January 28, 2017 |
Estimated Primary Completion Date : | December 31, 2021 |
Estimated Study Completion Date : | December 31, 2021 |
Group/Cohort | Intervention/treatment |
---|---|
Regular treatment |
Other: no intervention
No intervention |
Treatment interruption |
Other: no intervention
No intervention |
- Changes of Proviral DNA levels [ Time Frame: The changes of baseline proviral DNA at 48 weeks ]quantitative proviral DNA measurement as the marker of HIV reservoir

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 20 Years to 50 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Confirmed HIV-1-infected patients
- 20-50 years old
- receiving antiretroviral therapy
Exclusion Criteria:
- Serious co-morbidity
- Obvious hepatic or renal dysfunction
- Receiving immunosuppressive therapy

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04068441
Contact: SZU-MIN Hsieh, M.D. | 886-2-23123456 ext 67736 | hsmaids@hotmail.com |
Taiwan | |
National Taiwan University Hospital | Recruiting |
Taipei, Taiwan, 100 | |
Contact: Szu-Min Hsieh, M.D. 886223123456 ext 67736 hsmaids@hotmail.com |
Principal Investigator: | Szu-Min Hsieh, M.D. | National Taiwan University Hospital |
Responsible Party: | National Taiwan University Hospital |
ClinicalTrials.gov Identifier: | NCT04068441 |
Other Study ID Numbers: |
201904090RINA |
First Posted: | August 28, 2019 Key Record Dates |
Last Update Posted: | September 23, 2020 |
Last Verified: | August 2020 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |